Sources | Names Used |
---|---|
CTRPv2 | BRD-K27188169:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-K27188169:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | WIPF1 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
mRNA | TLE4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | TNFRSF10D | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
mRNA | SYT14 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | TTF1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | MYPOP | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | FAM110D | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
mRNA | CEP95 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.02 |
mRNA | AKR1D1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.02 |
mRNA | ARPP21 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |